Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EANM perspectives for CZT SPECT in brain applications.
Verger A, Cecchin D, Guedj E, Albert NL, Brendel M, Fraioli F, Tolboom N, Traub-Weidinger T, Yakushev I, Van Weehaeghe D, Fernandez PA, Garibotto V, Imbert L. Verger A, et al. Among authors: fraioli f. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3680-3684. doi: 10.1007/s00259-024-06788-6. Eur J Nucl Med Mol Imaging. 2024. PMID: 38858281 No abstract available.
2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee.
Verger A, Barthel H, Tolboom N, Fraioli F, Cecchin D, Albert NL, van Berckel B, Boellaard R, Brendel M, Ekmekcioglu O, Semah F, Traub-Weidinger T, van de Weehaeghe D, Morbelli S, Guedj E. Verger A, et al. Among authors: fraioli f. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3599-3606. doi: 10.1007/s00259-022-05913-7. Eur J Nucl Med Mol Imaging. 2022. PMID: 35840817 Free PMC article. No abstract available.
EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.
Van Weehaeghe D, Lapauw B, Fraioli F, Cecchin D, Verger A, Guedj E, Albert NL, Brendel M, Yakushev I, Barthel H, Traub-Weidinger T, Tolboom N, Giessen EV. Van Weehaeghe D, et al. Among authors: fraioli f. Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2367-2370. doi: 10.1007/s00259-024-06728-4. Eur J Nucl Med Mol Imaging. 2024. PMID: 38687371 No abstract available.
Non-small-cell lung cancer resectability: diagnostic value of PET/MR.
Fraioli F, Screaton NJ, Janes SM, Win T, Menezes L, Kayani I, Syed R, Zaccagna F, O'Meara C, Barnes A, Bomanji JB, Punwani S, Groves AM. Fraioli F, et al. Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):49-55. doi: 10.1007/s00259-014-2873-9. Epub 2014 Aug 15. Eur J Nucl Med Mol Imaging. 2015. PMID: 25120040 Free PMC article.
Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF).
Fraioli F, Lyasheva M, Porter JC, Bomanji J, Shortman RI, Endozo R, Wan S, Bertoletti L, Machado M, Ganeshan B, Win T, Groves AM. Fraioli F, et al. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2023-2031. doi: 10.1007/s00259-019-04386-5. Epub 2019 Jul 8. Eur J Nucl Med Mol Imaging. 2019. PMID: 31286201 Free PMC article.
Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).
Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, Endozo R, Shortman RI, Hurrell L, Holman BF, Thielemans K, Rashidnasab A, Hutton BF, Lukey PT, Flynn A, Ell PJ, Groves AM. Win T, et al. Among authors: fraioli f. Eur J Nucl Med Mol Imaging. 2018 May;45(5):806-815. doi: 10.1007/s00259-017-3917-8. Epub 2018 Jan 16. Eur J Nucl Med Mol Imaging. 2018. PMID: 29335764 Free PMC article. Clinical Trial.
COVID-19; beyond the obvious: how do we move forward?
Nasoodi A, Johnston C, Fraioli F. Nasoodi A, et al. Among authors: fraioli f. Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2070-2071. doi: 10.1007/s00259-020-04905-9. Epub 2020 Jun 11. Eur J Nucl Med Mol Imaging. 2020. PMID: 32529289 Free PMC article. No abstract available.
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Chen SH, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM. Chen SH, et al. Among authors: fraioli f. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):371-384. doi: 10.1007/s00259-021-05318-y. Epub 2021 Apr 10. Eur J Nucl Med Mol Imaging. 2021. PMID: 33837843 Free PMC article.
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Chen SH, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM. Chen SH, et al. Among authors: fraioli f. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):786-787. doi: 10.1007/s00259-021-05546-2. Eur J Nucl Med Mol Imaging. 2022. PMID: 34894284 Free PMC article. No abstract available.
PET imaging in glioma: techniques and current evidence.
Mansoor NM, Thust S, Militano V, Fraioli F. Mansoor NM, et al. Among authors: fraioli f. Nucl Med Commun. 2018 Dec;39(12):1064-1080. doi: 10.1097/MNM.0000000000000914. Nucl Med Commun. 2018. PMID: 30303860 Review.
192 results